Clinical Biomarkers Market is Expected to Reach $53.20 Billion by 2033: BIS Research

Clinical biomarkers are essential indicators in healthcare and medical research, offering insights into physiological and pathological processes, disease progression, and treatment efficacy. They encompass various molecules like proteins, nucleic acids, and metabolites. The global clinical biomarkers market is experiencing notable growth driven by increased product usage, industry investments, and government initiatives. 

Key drivers include the rising demand for drug discovery and disease risk assessment biomarkers. According to BIS Research, the clinical biomarkers market was valued at $24.80 billion in 2023. The market is projected to reach $53.20 billion by 2033, growing at a CAGR of 7.93% from 2023 to 2033. Recent innovations include Abbott Laboratories' Alinity i Lab-Based Blood Test and Illumina Inc.'s TruSight Oncology 500 ctDNA v2.  

Access Market Insights: Clinical Biomarkers Market 

Clinical Biomarkers Market Analysis: Drivers, Opportunities and Challenges 

The global clinical biomarkers market is primarily fueled by the growing need for advanced products driven by the escalating cancer incidence worldwide. Major industry players are changing their technologies to align with market demands, especially given the increasing cancer diagnosis rates and the healthcare sector's emphasis on efficient diagnostic tools. Nonetheless, challenges emerge due to the high costs associated with products and services, impeding their adoption in low-income nations because of the substantial investment required. Expensive equipment, essential for laboratory operations, significantly contributes to the considerable capital outlay needed. 

Despite these challenges, there are opportunities for technological advancements in biomarker testing. Methods such as ELISA, gel electrophoresis, SPR, BioCD protein arrays, SERS, colorimetric, electrochemical assays, and fluorescence techniques offer precise detection capabilities. These advancements not only improve diagnostic accuracy but also have the potential to broaden market reach, addressing global healthcare challenges related to cancer detection and treatment. 

BIS Research, a leading market research firm, has released a report titled- Clinical Biomarkers Market, which discusses the challenges, growth factors, and future opportunities driving the market's remarkable growth. The detailed study is a compilation of market data tables and figures spread across several pages.    

Evaluate Free Sample Report: Download Sample Report 

Key Players in the Clinical Biomarkers Market  

Some of the prominent names profiled in the clinical biomarkers market report include: 

•   Abbott Laboratories 

•   Agilent Technologies, Inc. 

•   ALCEN 

•   Arsenal Capital Partners 

•   Azenta Life Sciences 

•   Becton, Dickinson and Company 

•   BGI 

•   bioMérieux S.A. 

•   Bio-Rad Laboratories, Inc. 

•   Broad Institute 

•   Caris Life Sciences 

•   CENTOGENE N.V. 

•   Charles River Laboratories 

•   Discovery Life Sciences (DLS) 

•   Enzo Biochem Inc. 

•   Eurofins Scientific 

•   F. Hoffmann-La Roche Ltd 

•   Illumina, Inc. 

•   Myriad Genetics, Inc. 

•   NeoGenomics Laboratories 

•   Novogene Co., Ltd. 

•   Personalis Inc. 

•   Q² Solutions 

•   QIAGEN N.V. 

•   Quest Diagnostics Incorporated 

•   Thermo Fisher Scientific Inc. 

Clinical Biomarkers Market Segments 

Segmentation 1: by Offering 

•   Product 

       o   Efficacy Biomarker 

       o      Safety Biomarker 

       o   Validation Biomarker 

•   Service 

       o   Genomic Biomarker Service 

       o   Tissue Biomarker Service 

       o   Cell Service 

       o   Proteomics Service 

Segmentation 2: by Clinical Area 

•   Cancer Biomarkers 

•   Cardiac Biomarkers 

•   Neurological Biomarkers 

•   Infectious Disease 

•   Immunological Biomarkers 

•   Non-Invasive Prenatal Testing 

•   Other Clinical Areas 

Segmentation 3: by Technology 

•   Next-Generation Sequencing (NGS) 

•   Polymerase Chain Reaction (PCR) 

•   Immunohistochemistry (IHC) 

•   Enzyme-linked immunosorbent Assay (ELISA) 

•   Other Technologies 

Segmentation 4: by End User 

•   Contract Research Organizations (CROs) 

•   Research and Academic Laboratories 

•   Biopharmaceutical and Biotech Companies 

•   Diagnostic Centers 

•   Other End Users 

Segmentation 5: by Region 

•   North America 

       o   U.S. 

       o   Canada 

•   Europe 

       o   Germany 

       o   U.K. 

       o   France 

       o   Italy 

       o   Spain 

       o   Rest-of-Europe 

•   Asia-Pacific 

       o   Japan 

       o   India 

       o   China 

       o   South Korea 

       o   Australia 

       o   Rest-of-Asia-Pacific 

•   Latin America 

       o   Brazil 

       o   Mexico 

       o   Rest-of-Latin America 

•   Rest-of-the-World 

Table of Contents   

1.1   Trends: Current and Future Impact Assessment  

1.2   Supply Chain Overview  

1.3   Research and Development Review  

1.4   Regulatory Landscape  

1.5   Stakeholder Analysis  

1.7   Market Dynamics Overview  

2.1   Application Segmentation  

2.2   Application Summary 

3.1   Product Segmentation 

3.2   Product Summary 

4.1   Regional Summary 

To Evaluate Report Coverage: Access Full TOC 

Other Related Reports from BIS Healthcare 

Global Sleep Apnea Oral Appliances Market 

Global Single-Use Assemblies Market 

Global Elderly Care Services Market 

Synthetic Hormones Market 

Analyst Take on the Clinical Biomarkers Market  

BIS principal analyst: Existing players in the clinical biomarkers industry are implementing diverse strategies to strengthen their market presence. These strategies include integrating artificial intelligence into biomarker discovery, expanding biomarker usage in precision medicine, and advancing technologies in clinical biomarker diagnosis. The comprehensive analysis provided in the global clinical biomarkers report offers valuable insights for manufacturers, service providers, and end users, enabling informed decision-making, targeted marketing, strategic planning, product benchmarking, and optimized resource allocation. 

About BIS Research 

BIS Research is a global B2B market intelligence and advisory firm focusing on deep technology and related emerging trends, which can disrupt the market dynamics in the near future. We publish over 200 market intelligence studies annually, focusing on several deep technology verticals.   

Our strategic market analysis emphasizes market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management.    

BIS Research offers syndicate and custom studies and expert consultations to firms, providing them with specific and actionable insights on novel technology markets, business models, and competitive landscapes.   

Contact 

Head of Marketing   

Email: media@bisresearch.com    

BIS Research Inc.   

39111 PASEO PADRE PKWY STE 313,   

FREMONT, CA 94538-1686   

Visit our Blog @https://bisresearch.com/insights   

Get Expert Insights @https://community.insightmonk.com    

Connect with us on LinkedIn @ https://www.linkedin.com/company/bis-research    

Connect with us on Twitter@ https://twitter.com/BISResearch